Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021)

Femasys (FEMY) reported Preferred Stock Liabilities of $55.3 million for Q1 2021, little changed quarter-over-quarter from $55.3 million in Q4 2020.

Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

Femasys has reported Preferred Stock Liabilities for 2 years, with the latest figure at $55.3 million in Q1 2021.

For the quarter ending Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $55.3 million; the trailing twelve-month figure through Mar 2021 stood at $55.3 million (changed N/A YoY), and the FY2020 full-year result was $55.3 million, changed N/A from the prior year.
Preferred Stock Liabilities for Q1 2021 stood at $55.3 million, roughly flat from $55.3 million in the prior quarter.
The five-year high for Preferred Stock Liabilities was $55.3 million in Q2 2020, with the low at $55.3 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	-
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Femasys	254.59 Mn	249.20 Mn	-	-

Download Data